Workflow
Galapagos(GLPG)
icon
Search documents
Galapagos(GLPG) - 2020 Q4 - Earnings Call Transcript
2021-02-20 02:06
Galapagos NV (NASDAQ:GLPG) Q4 2020 Earnings Conference Call February 19, 2021 8:00 AM ET Company Participants Elizabeth Goodwin - Vice President, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Piet Wigerinck - Chief Scientific Officer Michele Manto - Chief Commercial Officer Conference Call Participants Laura Sutcliffe - UBS AG Peter Welford - Jefferies Brian Abrahams - RBC Capital Markets ...
Galapagos(GLPG) - 2020 Q3 - Earnings Call Transcript
2020-11-07 02:21
Galapagos NV (NASDAQ:GLPG) Q3 2020 Results Conference Call November 6, 2020 8:00 AM ET Company Participants | --- | |-----------------------------------------------------| | | | Elizabeth Goodwin - Investor Relations | | Onno van de Stolpe - Chief Executive Officer | | Andre Hoekema - Chief Business Officer | | Bart Filius - Chief Operating and Financial Officer | | Walid Abi-Saab - Chief Medical Officer | | Piet Wigerinck - Chief Scientific Officer | | Michele Manto - Chief Commercial Officer | | Conferenc ...
Galapagos(GLPG) - 2020 Q3 - Earnings Call Presentation
2020-11-06 19:08
| --- | --- | |-------------------------------------------------------------|-------| | | | | Q3 2020 results | | | webcast | | | Onno van de Stolpe, CEO Piet Wigerinck, CSO 6 November 2020 | | | | | Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline, the statements regarding the global R&D collaboration with Gilead, statements relating to interactions with regulatory authorities, the timing or likeliho ...
Galapagos ADR (GLPG) Investor Presentation - Slideshow
2020-09-25 18:02
Galápagos We discover We dare We care Investor Relations slides | August 2020 1 Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline, the statements regarding the global R&D collaboration with Gilead, the amount and timing of potential future milestone, opt-in and/or royalty payments by Gilead, statements relating to interactions with regulatory authorities, the potential approval process for filgotinib a ...
Galapagos(GLPG) - 2020 Q2 - Earnings Call Transcript
2020-08-07 18:06
Galapagos NV (NASDAQ:GLPG) Q2 2020 Results Earnings Conference Call August 7, 2020 8:00 AM ET Company Participants Good day, and welcome to the Galapagos Half Year Results Call. At this time, I'd like to turn the conference over to Ms. Elizabeth Goodwin. Please go ahead. Elizabeth Goodwin Thank you all for joining us today for the audio webcast of Galapagos' First Half 2020 Results. I'm Elizabeth Goodwin, Investor Relations, also representing a great reporting team. This recorded webcast is accessible via t ...
Galapagos(GLPG) - 2020 Q1 - Earnings Call Transcript
2020-05-09 12:32
Galapagos NV (NASDAQ:GLPG) Q1 2020 Results Conference Call May 8, 2020 8:00 AM ET Company Participants Elizabeth Goodwin - Investor Relations Onno van de Stolpe - CEO Bart Filius - COO and CFO Piet Wigerinck - Chief Scientific Officer Walid Abi-Saab - Chief Medical Officer Michele Manto - Chief Commercial Officer Conference Call Participants Christopher Marai - Nomura Securities Jason Gerberry - Bank of America Evan Seigerman - Credit Suisse Wimal Kapadia - Bernstein Debjit Chattopadhyay - H.C. Wainwright B ...
Galapagos(GLPG) - 2019 Q4 - Annual Report
2020-03-27 20:41
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY R ...
Galapagos(GLPG) - 2019 Q4 - Earnings Call Transcript
2020-02-21 18:56
Galapagos NV (NASDAQ:GLPG) Q4 2019 Earnings Conference Call February 21, 2020 8:00 AM ET Company Participants Elizabeth Goodwin - Vice President, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Piet Wigerinck - Chief Scientific Officer Michele Manto - Chief Commercial Officer Conference Call Participants Dane Leone - Raymond James Rushee Jolly - Bernstein Christopher Marai - Nomura Instinet ...
Galapagos(GLPG) - 2019 Q3 - Earnings Call Transcript
2019-10-25 23:46
Galapagos NV (NASDAQ:GLPG) Q3 2019 Results Conference Call October 25, 2019 8:00 AM ET Company Participants | --- | |-------------------------------------------| | | | | | Elizabeth Goodwin - VP, IR | | Onno van de Stolpe - CEO | | Bart Filius - COO and CFO | | Walid Abi-Saab - CMO | | Piet Wigerinck - Chief Scientific Officer | | Conference Call Participants | | Eliana Merle - Cantor Fitzgerald | | Brian Abrahams - RBC Capital Markets | | Connor Meehan - Morgan Stanley | | Adam Walsh - Stifel | | Wimal Kap ...
Galapagos(GLPG) - 2019 Q2 - Earnings Call Transcript
2019-07-26 17:51
Galapagos NV (NASDAQ:GLPG) Q2 2019 Earnings Conference Call July 26, 2019 8:00 AM ET Company Participants Elizabeth Goodwin - VP, IR & Corporate Communications Onno van de Stolpe - Co-Founder, MD, CEO & Executive Director Bart Filius - CFO & COO Walid Abi-Saab - Chief Medical Officer Conference Call Participants Rushee Jolly - Sanford C. Bernstein & Co. Evan Seigerman - Crédit Suisse Emily Field - Barclays Bank Brian Abrahams - RBC Capital Markets James Quigley - JPMorgan Chase & Co. Eliana Merle - Cantor F ...